A Cell Cycle Progression-Derived Gene Signature to Predict Prognosis and Therapeutic Response in Hepatocellular Carcinoma

Figure 5

Establishment of a reliable nomogram for HCC prognosis in TCGA-LIHC cohort. (a) The nomogram that contained CCP-derived RS and stage for prediction of 1-, 3-, and 5-year survival probabilities of HCC. (b) ROC curves for verifying the predictive performance of this nomogram. (c) Comparison of nomogram-estimated and actual 1-, 3-, and 5-year survival probabilities of HCC. (d) Comparison of net benefit among none, all, stage, CCP-derived RS, and nomogram.

(a)

(b)

(c)

(d)